The MRC Confidence in Concepts at UCL Fund 2015

Lead Research Organisation: University College London
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach –– before seeking more substantive funding.  It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.

People

ORCID iD

Publications

10 25 50

publication icon
Fernando O (2018) Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery. in Molecular therapy : the journal of the American Society of Gene Therapy

publication icon
Subramaniam S (2018) Perinatal Stem Cells

publication icon
Yaghmoor RB (2020) Effect of Novel Antibacterial Composites on Bacterial Biofilms. in Journal of functional biomaterials

publication icon
Alkhouri N (2022) Renewal MI Dental Composite Etch and Seal Properties. in Materials (Basel, Switzerland)

 
Description BRC - Anne Young
Amount £59,130 (GBP)
Organisation University College Hospital 
Sector Hospitals
Country United Kingdom
Start  
 
Description BRC Feasibility - Heywood
Amount £15,150 (GBP)
Organisation Great Ormond Street Hospital (GOSH) 
Sector Hospitals
Country United Kingdom
Start  
 
Description EPSRC First Grant, Matt Clarckson
Amount £99,906 (GBP)
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 08/2016 
End 07/2017
 
Description Moorfields Eye Charity, Cynthia Yu-Wai-Man
Amount £82,402 (GBP)
Organisation Moorfields Eye Charity 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2017 
End 12/2017
 
Description NIHR Fellowship award, Mahdad Noursadeghi
Amount £1,200,000 (GBP)
Organisation National Institute for Health Research 
Department NIHR Fellowship Programme
Sector Public
Country United Kingdom
Start 04/2017 
End 03/2022
 
Description NIHR i4i Product Development Award, Matt Clarkson
Amount £1,470,000 (GBP)
Organisation National Institute for Health Research 
Department NIHR i4i Invention for Innovation (i4i) Programme
Sector Public
Country United Kingdom
Start 01/2018 
End 12/2021
 
Description Newton Fund Fellowship, Anne Young
Amount £108,000 (GBP)
Organisation Newton Fund 
Sector Public
Country United Kingdom
Start 05/2017 
End 04/2019
 
Description Real-Time Ultrasound Guided Abdominal Interventions Without a Tracking Device
Amount £1,015,268 (GBP)
Funding ID EP/T029404/1 
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 06/2020 
End 06/2023
 
Description UCL TAS fund, Sam Janes
Amount £73,057 (GBP)
Organisation University College London 
Sector Academic/University
Country United Kingdom
Start 01/2018 
End 12/2018
 
Title CELL DEATH BIOMARKER 
Description The invention relates to cell death of cancer cells, and in particular to biomarkers that may be used to identify cancer cells that are sensitive to death receptor ligand (DRL)- induced cell death. The invention also extends to prognostic methods and kits for identifying cancer cells that are sensitive to DRL-induced cell death. The invention further extends to novel compositions and therapeutic methods using such compositions for treating cancer. 
IP Reference WO2018051110 
Protection Patent application published
Year Protection Granted 2018
Licensed No
Impact Still in development
 
Title Nanoparticles for Cancer Therapy and Diagnosis 
Description The present invention relates generally to methods and materials for use in photothermal or sonodynamic therapy. The invention novel nanoparticles for use in delivering sensitizers to solid tumour target, wherein the nanoparticles are composed of a polymers or co-polymer of monomers linked by peptide bonds, wherein the polymer or co-polymer comprises one or both of glutamate or derivatised glutatamic acid, and optionally a further, different, monomer which is a naturally occurring amino acid or synthetic monomer having a side chain group, wherein the polymer or co-polymer is not composed only of glutamate. The pendant groups and/or side chains of the polymer or co-polymer interact non-covalently with the sensitizer. 
IP Reference US2020330598 
Protection Patent application published
Year Protection Granted 2020
Licensed No
Impact In further development
 
Title ULTRASOUND REGISTRATION 
Description A computer implemented method is disclosed for identifying a pose of a probe by registering an ultrasound image from with volumetric scan data. The volumetric scan data is processed (31) to determine simulated ultrasound images corresponding with a plurality of different poses of the probe. A feature vector is extracted (32) from each of the simulated ultrasound images and from the ultrasound image. The feature vector from the ultrasound image is compared (33) with each feature vector of the simulated ultrasound images to determine a distance or similarity for each simulated ultrasound image. At least one candidate image is selected (34), the at least one candidate image comprising a subset of the simulated ultrasound images that best matches the ultrasound image, based on the distance or similarity. The pose of the probe is identified (35) from the at least one candidate image. 
IP Reference WO2021019217 
Protection Patent / Patent application
Year Protection Granted 2021
Licensed No
Impact none as yet,